Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
With
National Institute on Drug Abuse (NIDA)
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Ability to provide informed consent
Age 18 to 45 years old
Stable health
7-day point prevalence abstinence demonstrated at randomization
Lifetime history of at least 100 cigarettes smoked
Quit smoking during the current pregnancy
Self-report of intention to remain abstinent after delivery ≥ 7 on a 10 point Likert-type scale
Uncomplicated delivery
Denies plans to become pregnant again during the trial.
Full-term delivery ≥ 37 weeks gestation
Home within 10 days of delivery
You may not be if
Current use of other forms of tobacco or nicotine (e-cigs, chew, snuff, etc.)
Current use of cessation aids (e.g., varenicline, NRT)
Current use of illicit drugs or alcohol dependence
Current use of antidepressant medication
Bipolar disorder, eating disorder, or psychotic disorder based on the Structured Clinical Interview
Medications \& conditions that may increase the risk of taking bupropion (e.g., current or history of pulmonary embolus, stroke, heart disease, kidney disease, glaucoma, diabetes, seizure disorder, traumatic head injury, use of medications metabolized by CYP2D6)
Family history of seizures or seizure disorder
Maternal use of medications that lower seizure threshold
Newborn with an elevated risk of seizure
Clareo Health | Bupropion for the Prevention of Postpartum Smoking Relapse
